Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2012-03-15Clinical Trial Update: Telomerase Activity as a Marker For Mobilization Quality
This clinical trial update discusses telomerase activity as a biomarker to assess mobilization quality in patients with lymphoma or multiple…
-
CLINICAL_TRIALS research · 2012-02-15Clinical Trial Update: Iberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 Years [Phase 3]
Phase 3 trial update on thalidomide for symptomatic newly diagnosed multiple myeloma in patients over 65.
-
CLINICAL_TRIALS research · 2011-09-27Clinical Trial Update: Study of the Best Timing for Plerixafor in Autologous Hematopoietic Stem Cell Collection [NA]
This document reports a clinical trial update evaluating the best timing for administering plerixafor during autologous hematopoietic stem c…
-
CLINICAL_TRIALS research · 2011-08-25Clinical Trial Update: Clinical Evaluation of the Serum Free Light Chain Analysis
This entry notes a clinical trial evaluating serum free light chain analysis as a diagnostic tool in multiple myeloma.
-
CLINICAL_TRIALS research · 2011-08-12Clinical Trial Update: A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma [Phase 1, Phase 2]
Clinical trial update on a Phase I/II study evaluating romidepsin in combination with bortezomib for relapsed multiple myeloma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2011-08-04Clinical Trial Update: Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating a chemoprevention therapy for individuals at high risk of developing multiple myeloma; the study status is…
-
CLINICAL_TRIALS research · 2011-06-15Clinical Trial Update: Study of CX-4945 in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]
A phase 1 clinical trial update for CX-4945 (silmitasertib) in relapsed or refractory multiple myeloma conducted by Cylene Pharmaceuticals.
-
CLINICAL_TRIALS research · 2010-12-01Clinical Trial Update: Technology Platform and System Construction of Clinical Evaluation Studies on New Drugs of Hematological Malignancy
Clinical trial update describing the technology platform and system construction for evaluating new drugs in hematologic malignancies, with …
-
CLINICAL_TRIALS research · 2010-10-29Clinical Trial Update: Host Dendritic Cells in Allograft Patients [Phase 1]
Phase 1 clinical trial update from Icahn School of Medicine at Mount Sinai evaluating host dendritic cells in allograft patients for relapse…
-
CLINICAL_TRIALS research · 2010-07-28Clinical Trial Update: The Pathophysiology of Bortezomib Induced Peripheral Neuropathy
An update on the pathophysiology of bortezomib-induced peripheral neuropathy in patients with multiple myeloma, outlining the mechanisms of …
-
CLINICAL_TRIALS research · 2010-07-02Clinical Trial Update: An Open Protocol for the Compassionate Use of Thalidomide [Phase 1, Phase 2]
Clinical trial update for an open compassionate-use protocol using thalidomide in multiple myeloma patients across Phase 1 and Phase 2. The …
-
CLINICAL_TRIALS research · 2010-01-28Clinical Trial Update: Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders [Phase 2]
A Phase 2 clinical trial update evaluating stem cell transplantation for hematological cancers or related disorders, listing conditions such…
-
CLINICAL_TRIALS research · 2009-06-01Clinical Trial Update: Study in Myeloma Patients Newly Diagnosed Treated as an Induction With Velcade-Dex or Velcade (Bortezomib) Thalidomide Dexamethasone (VTD) [Phase 3]
Phase 3 clinical trial evaluating induction regimens Velcade-Dex versus Velcade-Thalidomide-Dexamethasone (VTD) in newly diagnosed multiple …
-
CLINICAL_TRIALS research · 2009-03-13Clinical Trial Update: Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple Myeloma [Phase 2]
This clinical trial update describes a Phase 2 study evaluating a four-drug regimen (bortezomib, cyclophosphamide, dexamethasone, and thalid…
-
CLINICAL_TRIALS research · 2009-01-13Clinical Trial Update: Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma [Phase 1]
This trial entry documents a Phase 1 study evaluating fluphenazine in patients with relapsed or relapsed-and-refractory multiple myeloma. Th…
-
CLINICAL_TRIALS research · 2008-12-09Clinical Trial Update: Autologous Stem Cell Transplant (ASCT) With Intravenous Busulfan and Melphalan as Conditioning Regimen [Phase 2]
Phase 2 clinical trial evaluating autologous stem cell transplantation using intravenous busulfan and melphalan as conditioning for multiple…
-
CLINICAL_TRIALS research · 2008-06-09Clinical Trial Update: Comparison Between FDG-PET and MRI for the Assessment of Response to Intensive Chemotherapy in Multiple Myeloma Patients. [NA]
This clinical trial update compares FDG-PET and MRI for assessing response to intensive chemotherapy in patients with multiple myeloma. The …
-
CLINICAL_TRIALS research · 2008-05-06Clinical Trial Update: TCD Followed by autoSCT for Newly Diagnosed MM Patients [Phase 2]
Phase 2 clinical trial by the Korean Multiple Myeloma Working Party evaluating TCD followed by autologous stem cell transplantation in newly…
-
CLINICAL_TRIALS research · 2007-10-19Clinical Trial Update: Multi Centre Trial of DSMM for Newly Diagnosed Multiple Myeloma up to 60 Years [Phase 3]
Phase 3 multi-center trial evaluating DSMM for newly diagnosed multiple myeloma in patients up to 60 years old.
-
CLINICAL_TRIALS research · 2006-12-28Clinical Trial Update: Non-Myeloablative Allogeneic Transplantation From Unrelated Donors in Multiple Myeloma [Phase 2]
A Phase 2 clinical trial evaluating non-myeloablative allogeneic transplantation from unrelated donors in multiple myeloma. The current stat…
-
CLINICAL_TRIALS research · 2006-11-07Clinical Trial Update: T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant [Phase 1, Phase 2]
This document provides an update on a Phase 1/Phase 2 clinical trial evaluating T cell immunotherapy for patients with multiple myeloma unde…
-
CLINICAL_TRIALS research · 2006-09-29Clinical Trial Update: Fludarabine Added to Induction Treatment in Untreated Multiple Myeloma Patients [Phase 2]
A Phase 2 clinical trial investigates adding fludarabine to induction therapy for patients with untreated multiple myeloma; the current stat…
-
CLINICAL_TRIALS research · 2006-09-22Clinical Trial Update: Sequential VAD and VTD Followed by HDT With ASCT and Velcade Maintenance for NDMM [Phase 2]
Phase 2 clinical trial in newly diagnosed multiple myeloma assessing sequential VAD and VTD induction followed by high-dose therapy with aut…